Kinase inhibitor ibrutinib to prevent cytokine-release syndrome after anti-CD19 chimeric antigen receptor T cells for B-cell neoplasms.
作者信息
Ruella M, Kenderian S S, Shestova O, Klichinsky M, Melenhorst J J, Wasik M A, Lacey S F, June C H, Gill S
机构信息
Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
出版信息
Leukemia. 2017 Jan;31(1):246-248. doi: 10.1038/leu.2016.262. Epub 2016 Sep 28.
PMID:27677739
Abstract
摘要
Zotero 插件